Cor Vasa 2010, 52(3):188-192 | DOI: 10.33678/cor.2010.047

Amyloidosis as a rare cause of dyspnea

Eva Kociánová1,*, Jan Václavík1, Miloš Táborský1, Marián Fedorco1, Pavel Folwarczny1, Tomáš Pika2, Yvona Hrčková1
1 I. interní klinika
2 III. interní klinika Fakultní nemocnice Olomouc a Lékařské fakulty Univerzity Palackého v Olomouci, Česká republika

We report the case of a 44-year-old man examined for dyspnea lasting several months with manifestations of heart failure. The patient developed the dyspnea after a protracted febrile condition. An electrocardiogram showing a scar on the anterior wall and left ventricular dysfunction with a 40% left ventricular ejection fraction (LVEF) and mild pericardial exudates led initially to suspected coronary heart disease ruled out by a negative coronary angiogram. Marked left ventricular hypertrophy on follow-up echocardiography and the finding of nephritic proteinuria made us consider a systemic disease. Heart magnetic resonance imaging excluded previous myocarditis and late subendocardial enhancement together with the detection of serum and urinary paraprotein, and a non-proportional increase in lambda free light chains, established the diagnosis of primary amyloidosis (AL) confirmed by biopsy. There was regression of signs of left-heart failure following titration of doses of a beta-blocker, ACE inhibitor and diuretics. The patient has been scheduled for chemotherapy in the ensuing months.

Keywords: Amyloidosis; Cardiomyopathy; Hypertrophy; Heart Failure

Published: March 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kociánová E, Václavík J, Táborský M, Fedorco M, Folwarczny P, Pika T, Hrčková Y. Amyloidosis as a rare cause of dyspnea. Cor Vasa. 2010;52(3):188-192. doi: 10.33678/cor.2010.047.
Download citation

References

  1. Hess OM, McKenna W, Schultheiss HP, et al. Myocardial Disease. In: Camm AJ, Lüscher TF, Serruys PW, et al. The ESC textbook of cardiovascular medicine. Oxford: Blackwell Publishing, 2006:478-479.
  2. Dubrey SW, Cha K, Anderson J, et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998; 91:141-157. Go to original source... Go to PubMed...
  3. Smith TJ, Kyle RA, Lie JT. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc 1984;59:547-555. Go to original source...
  4. Feng D, Edwards WD, Oh JK, et al. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation 2007;116:2420-2426. Go to original source...
  5. Murtagh B, Hammill SC, Gertz MA, et al. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol 2005;95:535-537. Go to original source...
  6. Dispenzieri A, Kyla RA, Gertz MA, et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 2003;361: 1787-1789. Go to original source...
  7. Klein AL, Hatle LK, Taliercio CP, et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1990;16:1135-1141. Go to original source...
  8. Rubinow A, Skinner M, Cohen AS. Digoxin sensitivity in amyloid cardiomyopathy. Circulation 1981;63:1285-1288. Go to original source...
  9. Gertz MA, Skinner M, Connors LH, et al. Selective binding of nifedipine to amyloid fibrils. Am J Cardiol 1985;55(13 Pt 1):1646. Go to original source...
  10. Pollak A, Falk RH. Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis. Chest 1993;104:618-620. Go to original source... Go to PubMed...
  11. Kristen, AV, Dengler, TJ, Hegenbart, U, et al. Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death. Heart Rhythm 2008;5:235-240. Go to original source... Go to PubMed...
  12. Palladini, G, Campana, C, Klersy, C, et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 2003;107:2440-2445. Go to original source... Go to PubMed...
  13. Ng B, Connors LH, Davidoff R, et al. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005; 165:1425-1429. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.